Janet Van Eersel

North Ryde, NSW 2109, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Genetic medicines for epilepsy: unlocking new avenues for seizure control.

Genetic medicines for epilepsy: unlocking new avenues for seizure control.

Journal: Frontiers in bioengineering and biotechnology

Published: December 16, 2025

Engineered Cyclotide Blocks Neuronal Excitotoxicity.

Engineered Cyclotide Blocks Neuronal Excitotoxicity.

Journal: Journal of medicinal chemistry

Published: December 04, 2024

Design of peptide therapeutics as protein-protein interaction inhibitors to treat neurodegenerative diseases.

Design of peptide therapeutics as protein-protein interaction inhibitors to treat neurodegenerative diseases.

Journal: RSC advances

Published: July 12, 2024

Treatment of epilepsy using a targeted p38γ kinase gene therapy.

Treatment of epilepsy using a targeted p38γ kinase gene therapy.

Journal: Science advances

Published: December 02, 2022

Recent progress in synthetic self-adjuvanting vaccine development.

Recent progress in synthetic self-adjuvanting vaccine development.

Journal: Biomaterials science

Published: June 16, 2022

The Nature of Diamino Linker and Halogen Bonding Define Selectivity of Pyrrolopyrimidine-Based LIMK1 Inhibitors.

The Nature of Diamino Linker and Halogen Bonding Define Selectivity of Pyrrolopyrimidine-Based LIMK1 Inhibitors.

Journal: Frontiers in chemistry

Published: September 22, 2021

Onset of hippocampal network aberration and memory deficits in P301S tau mice are associated with an early gene signature.

Onset of hippocampal network aberration and memory deficits in P301S tau mice are associated with an early gene signature.

Journal: Brain : a journal of neurology

Published: September 24, 2019

Contribution of endogenous antibodies to learning deficits and astrocytosis in human P301S mutant tau transgenic mice.

Contribution of endogenous antibodies to learning deficits and astrocytosis in human P301S mutant tau transgenic mice.

Journal: Scientific reports

Published: August 13, 2019

Novel Behavioural Characteristics of Male Human P301S Mutant Tau Transgenic Mice - A Model for Tauopathy.

Novel Behavioural Characteristics of Male Human P301S Mutant Tau Transgenic Mice - A Model for Tauopathy.

Journal: Neuroscience

Published: June 17, 2019

Sphingosine Kinase 2 Potentiates Amyloid Deposition but Protects against Hippocampal Volume Loss and Demyelination in a Mouse Model of Alzheimer's Disease.

Sphingosine Kinase 2 Potentiates Amyloid Deposition but Protects against Hippocampal Volume Loss and Demyelination in a Mouse Model of Alzheimer's Disease.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience

Published: March 10, 2019

The Polyphenol Altenusin Inhibits in Vitro Fibrillization of Tau and Reduces Induced Tau Pathology in Primary Neurons.

The Polyphenol Altenusin Inhibits in Vitro Fibrillization of Tau and Reduces Induced Tau Pathology in Primary Neurons.

Journal: ACS chemical neuroscience

Published: January 10, 2017

Mouse models of frontotemporal dementia: A comparison of phenotypes with clinical symptomatology.

Mouse models of frontotemporal dementia: A comparison of phenotypes with clinical symptomatology.

Journal: Neuroscience and biobehavioral reviews

Published: September 13, 2016

Showing 1-12 of 19

Last Updated: 09/26/2026